glp-1 ra mechanism Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review Glucagon-like peptide-1 receptor: mechanisms and

However, the existing evidence is limited by small cohort sizes, heterogeneous patient populations, and confounding effects of concurrent therapies, limiting its generalizability

Aspartate Aminotransferase (AST)

Weight loss medications have rapidly moved from the margins of diabetes care into the center of conversations about wellness and the future of food

Maria Kalaitzandonakes, Brenna Ellison, Trey Malone, and Jonathan Coppess - Maria Kalaitzandonakes -

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.